Flucosyd is a broad spectrum oral anti-fungal agent in capsule form. It has Fluconazole as an active constituent which belongs to the Azole class.
- Vaginal candidiasis.
- Systemic candidiasis.
- Oropharyngeal/Oespharyngeal candidiasis.
- Prophylaxis of fungal infections.
The principal mode of action of Flucosyd is to preferentially inhibit cytochrome p450 enzyme present in fungi.
|Single dose therapy.||Improves compliance.|
|Systematic action.||Ensures high cure rate and prevents reoccurrence.|
|Rapid symptom relief.||High degree of patient satisfaction.|
|Highly cost effective.||Affordable for patient.|
Vaginal candidiasis: 150mg oral capsule as a single dose.
Dermatophytosis: 50mg oral capsule daily for 14 – 28 days or 150mg oral single dose weekly for 6 – 8 weeks.
Oropharyngeal/Oesophharyngeal candidiasis: 100mg stat orally, then 50mg daily for 14 days.